Status:
COMPLETED
Electromyographic and Acceleromyographic Monitoring in Restricted Arm Movement Surgical Setting
Lead Sponsor:
Mayo Clinic
Conditions:
Residual Neuromuscular Blockade
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Researchers are comparing the ease of use and repeatability of the force vs electrical activity produced by a muscle after it has undergone nerve stimulation during a surgical procedure in which the p...
Eligibility Criteria
Inclusion
- Age \> or = 18 years old
- Patients willing to participate and provide an informed consent
- Patients undergoing an elective laparoscopic or robotic surgical procedure that requires use of NMBA agents administered intraoperatively.
Exclusion
- Patients with disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury.
- Patients with systemic neuromuscular diseases such as myasthenia gravis
- Patients with significant organ dysfunction that can significantly affect pharmacokinetics of neuromuscular blocking and reversal agents, i.e., severe renal impairment or end-stage liver disease.
- Patients having surgery that would involve prepping the arm or leg into the sterile field
Key Trial Info
Start Date :
August 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04352140
Start Date
August 18 2020
End Date
February 14 2022
Last Update
February 17 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224
2
Université de Lorraine, CHU de Brabois
Vandœuvre-lès-Nancy, France, 54511
3
University of Debrecen
Debrecen, Hungary, 4031